Andrew Menzies‐Gow
AstraZeneca (United Kingdom)(GB)University of Ulster(GB)Guy's and St Thomas' NHS Foundation Trust(GB)John Hunter Hospital(AU)Harefield Hospital(GB)Hunter Medical Research Institute(AU)Royal Brompton Hospital(GB)AstraZeneca (France)(FR)AstraZeneca (Singapore)(SG)AstraZeneca (Switzerland)(CH)Royal Victoria Hospital(GB)AstraZeneca (Poland)(PL)Imperial College London(GB)University of Newcastle Australia(AU)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery, Eosinophilic Esophagitis
Most-Cited Works
- → Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma(2021)914 cited
- → Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics(2003)840 cited
- → Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway(2003)804 cited
- → An expert consensus framework for asthma remission as a treatment goal(2019)372 cited
- → The Biology of Eosinophils and Their Role in Asthma(2017)352 cited
- → Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management(2019)350 cited